Methanex Reports Higher First Quarter 2024 Earnings as Methanol Prices Increase
April 24, 2024 17:03 ET
|
Methanex Corporation
Except where otherwise noted, all currency amounts are stated in United States dollars. Net income attributable to Methanex shareholders of $53 million and Adjusted EBITDA of $160 million in the...
Methanex Renews and Adds New Tranche to Revolving Credit Facility
April 24, 2024 17:00 ET
|
Methanex Corporation
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Methanex Corporation (TSX:MX) (NASDAQ:MEOH) announced today that it has renewed its US$300 million revolving credit facility, which...
ChampionX Reports First Quarter 2024 Results
April 24, 2024 17:00 ET
|
ChampionX Corporation
Revenue of $922.1 million, decreased 3% year-over-yearNet income attributable to ChampionX of $112.9 million, increased 78% year-over-yearAdjusted net income of $96.4 million, increased 17%...
Marathon Digital Holdings Schedules Conference Call for First Quarter 2024 Financial Results
April 24, 2024 16:54 ET
|
Marathon Digital Holdings Inc.
Earnings Webcast and Conference Call Set for Thursday, May 9, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, April 24, 2024 (GLOBE NEWSWIRE) -- Marathon Digital Holdings, Inc. (NASDAQ:MARA) ("Marathon"...
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
April 24, 2024 16:51 ET
|
Ocean Biomedical, Inc.
PROVIDENCE, Rhode Island, April 24, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on April 18, 2024, it received a notice from The Nasdaq Stock Market...
Amedisys Reports First Quarter 2024 Financial Results
April 24, 2024 16:45 ET
|
Amedisys, Inc.
BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended...
CVB Financial Corp. Reports Earnings for the First Quarter 2024
April 24, 2024 16:45 ET
|
CVB Financial Corp
First Quarter 2024 Net Earnings of $48.6 million, or $0.35 per share Return on Average Assets of 1.21%Return on Average Tangible Common Equity of 15.13% Net Interest Margin of 3.10% ...
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024 16:45 ET
|
NKGen Biotech, Inc.
SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and...
Riot Announces First Quarter 2024 Earnings Conference Call
April 24, 2024 16:45 ET
|
Riot Platforms, Inc
Castle Rock, CO, April 24, 2024 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), an industry leader in vertically integrated Bitcoin (“BTC”) mining, announced today...
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
April 24, 2024 16:40 ET
|
Nanobiotix S.A.
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102...